STUDIES ON IMMUNITY IN CANCERS OF THE WHITE RAT by Levin, Isaac
STUDIES  ON  IMMUNITY  IN  CANCERS  OF  THE 
WHITE  RAT} 
BY  ISAAC LEVIN. 
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The  most  important  biological  phenomenon  observed  in  the 
experimental study of the transplantable tumors of the white  rats 
and mice consists in the so-called immunity or resistance of certain 
animals  to  the  growth  of  these  implantations.  This  resistance 
apparently depends upon a  number of various complex conditions, 
most of which as  yet present  no  tangible explanation.  It consists 
in every case of two components, one of which is the power of the 
implanted cancer cell to unlimited proliferation, and the other,  the 
reactivity of the  host.  When  a  spontaneous tumor  is  inoculated, 
it grows successfully only in a  small number of the  animals used, 
frequently  in  less  than  IO  per  cent.  In  subsequent  inoculations 
with material taken  from the implanted tumors, the success of the 
takes  increases  until  it may reach  fully IOO  per  cent.,  which  indi- 
cates that the implanted cancer cell increases its proliferating power 
--its virulence.  The fact, on the other hand, that during all these 
transplantations a  certain number of animals retain their immunity 
to the growth of the tumor, clearly shows the influence of the reac- 
tivity of the host.  This latter quality is considered by the majority 
of the investigators to be a  natural characteristic of this animal, a 
natural immunity. 
Immunity may  also  be  induced artificially by  various  methods. 
Ehrlich ( I ), who first succeeded in rendering an animal resistant by 
artificial means, proceeded in the following  manner.  He inoculated 
a  certain number of animals with a spontaneous hemorrhagic tumor, 
the cells of which were known to be of very low virulence and to 
absorb  in  nearly  every  animal  without producing a  growth.  He 
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then  inoculated  the  same  animals  with  a  very virulent  tumor  with 
the result that  a  greater number  of the treated  animals  were resist- 
ant  to the  implantation  of the  virulent  strain  than  the  control  ani- 
mals, and this resistance  held  good against the subsequent inoculation 
of nearly  every other  transplantable  tumor,  whether  carcinoma  or 
sarcoma.  This  phenomenon,  which  Ehrlich  calls  pan-immunity, 
appears  to  have  a  very wide  application,  and  as  is  shown  by the 
investigations  of  Bashford  (2),  Schoene  (3),  Borrel  (4)  and 
Bridr6  (5),  may be induced  by previous  treatment,  not  only  with 
tumor  tissue,  but  also  with  different  normal  organ  tissue  of  the 
same  species  of  animals.  Thus  the  immunity,  or  resistance  to 
growth of tmnor, does not appear to have a clearly specific character. 
Ehrlich  maintains  further  that  animals  on  whom  a  successful 
inoculation of another tumor was done previously, i. e., animals that 
had  a  tumor  growth,  appeared  to be immune  against  a  subsequent 
inoculation either of the same or another tumor.  This  observation 
was one of the main  factors which  served Ehrlich  in the construc- 
tion of his "atreptic"  hypothesis of the immunity to tumor growth. 
Every implanted  cancer cell,  according to his  idea,  requires  for the 
success of its further  proliferation  a  specific food which  it finds  in 
the organisms of the host.  When the  first tumor is implanted  into 
the animal,  it takes up all the specific food available in the organism 
and  consequently  the  cancer  cell  subsequently  inoculated  does  not 
find in  the  host  any of this  specific food, and,  therefore,  no tumor 
growth  takes  place.  This  hypothesis  of  Ehrlich's  will  be  consid- 
ered with more detail later, but it must be stated here that both this 
theory and the phenomenon itself did not seem to find any corrobo- 
ration  among the subsequent investigators. 
Hertwig  and  Poll  (6),  Gierke  (7),  and  Borrel,  on  repeating 
these experiments,  found opposite results.  Borrel as well as Gierke 
explain this discrepancy by the difference in the technique employed 
in their  investigations.  They inoculated  small pieces of the tumor 
under the skin,  while Ehrlich  used an emulsion.  They believe that 
when  an  emulsion  is  used,  only  a  small  number  of  the  cells  pro- 
liferate,  while  the  rest  is  absorbed  and  consequently  produces  an 
immunity  against  subsequent  inoculation.  When  a  small  piece  is 
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liferation,  no  artificial  immunity  is  produced,  and  the  subsequent 
inoculation is successful. 
Nor does Borrel agree  with  Ehrlich's  explanation  of his  results, 
that  the  immunity  to  the  growth  of  cancer  depends  upon  certain 
peculiarities  in the  distribution  of  food, but believes that  it is anal- 
ogous to  the  bacterial  immunity  and  is  caused  by certain  cytolytic 
anti-bodies  circulating  in  the  blood.  He  maintains  that  the  first 
tumor grew  in the animal  because the  anti-bodies  did  not have the 
time  to  develop,  and  when  they  do  develop,  they  cannot  interfere 
with  the  continued  growth  of the  first tumor,  but they may  inter- 
fere successfully with  the  grafting  of the  second tumor.  Ehrlich, 
on the other hand,  explains the lack of corroboration of his  finding 
by the  fact that  he always uses  in  his  experiments  a  very virulent 
tumor for the first inoculation, a tumor which according to his ideas 
is best able to obtain  all the specific food  from the  host,  while the 
other  investigators  use  tumors  of  less  virulence,  and  there  conse- 
quently remains in the organism a  sufficient amount of specific food 
for  the  successful  growth  of  the  subsequent  inoculation.  This 
explanation  of Ehrlich's  seemed to find proof in the experiments of 
Apolant  (8)  with  mixtures  of  emulsions  of  the  two  different 
tumors, sarcoma and carcinoma,  for instance.  At first he produced 
on  such inoculation  a  tumor with the  character  both of carcinoma 
and sarcoma, but if one of the tumors used was more virulent than 
the  other,  then  its character  prevailed  in  the  implanted  tumor  and 
the cells of the other tumor were suppressed.  When all these  facts 
are  analyzed,  the  weight  of  evidence  seems  to  tend  to  the  possi- 
bility that  the  experiments  of Ehrlich,  Gierke,  and  Borrel  may all 
be correct and the differences are not due to  faulty methods, but to 
the fact that the conditions are different in these various experiments. 
Two factors have to be accounted for in the consideration  of the 
powers of resistance of the host to tumor growth.  When a  tumor 
is inoculated, the cells are grafted on the host, and whether the graft 
will  be  successful or  not  depends  upon  the  ability  of  the  host  to 
supply  a  connective  tissue  stroma  or  "scaffolding,"  as  Bashford 
calls  it.  It  also  depends  upon  the  amount  of  the  vascularization 
of this  stroma.  Russell  (9)  has  shown  that  the  difference  in the 
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tumor graft consists just in such a  difference of the  formation of a 
stroma.  Indeed the investigations of the writer  (IO) seem to make 
it  plausible that  the  fact of the  success of the  implantation  of the 
cancers  of the  white  rat  and  mouse, as compared  with  other  labo- 
ratory animals,  may be explained by such a  great cellular reactivity 
of these animals.  It seems feasible that  during this stage of graft- 
ing or cohesion of the implanted  cells to the host the  result  will be 
identical  whether  this  cell  possesses great  power  for  proliferation, 
or simply a  normal  embryonic cell,  as  in the  experiments  of Aska- 
nazy  (I I).  On  the  other  hand,  after  the  implanted  cancer  cell 
becomes ingrafted  and  is consequently able to develop its prolifer- 
ating  power,  it  again  depends  upon  an  interaction  of  a  different 
nature  between  the  implanted  cell  and  the  resistance  of  the  host, 
whether  there  will  take  place  unlimited  proliferation  and  growth 
of  cancer,  or  whether  the  cancer  cell  will  succeed  only  in  prolif- 
erating  for  a  while,  will  form  a  small  nodule  and  then  become 
absorbed,  and  consequently will be just as innocuous to  the organ- 
ism of the host as an implantation  of normal tissue.  Every worker 
in  cancer  inoculation  knows  by  experience  that  when  pieces  of  a 
tumor  are  implanted  in  a  set  of  animals,  there  will  take  place  a 
tumor  growth  in  a  certain  number  of animals,  in  others  the  graft 
will  disappear  completely,  while  in  others  again  there  will  appear 
a  small nodule,  which will later  disappear.  The  two latter  sets of 
animals are both ultimately immune to the inoculation of the tumor. 
It  stands  to  reason to suppose that  resistance  to the  grafting  of 
the implanted  cell and resistance to its subsequent unlimited growth 
may be produced in a  different manner.  Such a  difference is very 
well illustrated  in the  fact that,  as was shown by Haaland  (I2),  a 
tumor inoculated  succeeds but poorly on a  gravid  animal,  while, on 
the other hand,  Herzog  (I3)  has shown that  when a  tumor animal 
becomes  pregnant,  the  tumor  appears  to  grow  faster.  In  other 
words,  pregnancy  produces  a  resistance  against  the  grafting  of 
tumor  cells,  while  it  enhances  the  proliferation  of the  tumor  cells 
present  in the organism.  It is possible then that  a  tumor may find 
conditions  favorable for its own growth and  at the same time pro- 
duce within the host an immunity to subsequent tumor implantation, 
as  was the  case in  Ehrlich's  experiment,  while  tumors  used by the 
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It is clear then that  an artificial  production  of immunity  against 
tumor  growth  depends  upon  a  great  variety  of  conditions,  nor  is 
there a  unanimity of opinion as regards the modus operandi of this 
phenomenon.  Borrel  inclines  to the  view that  the  organism  of an 
imnmne  animal  contains  some  anti-bodies  of  a  peculiar  nature, 
which  restrain  the  growth,  or  rather  exert  a  toxic  influence  upon 
the  implanted  cells,  while  Ehrlich  and  Bashford  maintain  that 
resistance to growth of implanted tumor is a  purely cellular activity 
and  that  an  artificial  inmmnity  can  be induced  only by inoculation 
of living  cells. 
But an analysis of the investigations  on immunity  does not seem 
to bear out fully the latter opinion.  When an animal  is immunized 
by a  previous  inoculation  of  normal  tissue,  all  this  tissue  is  com- 
pletely absorbed by the time the tumor is inoculated,  ten days later. 
Very  instructive  in  this  connection  is  the  work of  Woglom  (14). 
He  found  that  the  spleen  extirpated  and  then  inoculated  subcu- 
taneously  into  the  same  animal  induces  resistance  against  growth 
of  tmnor.  Extirpation  of  the  spleen  alone  does  not  induce  any 
resistance.  If the resistance is caused in this case by the live func- 
tions of the cells of the spleen, they could act most effectively when 
the  spleen was in sit~,  and  the  mice  ought  to  have  been naturally 
resistant.  It  is true  that  blood serum  deprived  of cells and  tissue 
heated  or  crushed  and  frozen,  do  not  appear  to  induce  immunity, 
but this  fact may be just as easily explained by the supposition that 
such  a  treatment  of tissue  is  too severe and  changes  the  chemical 
composition  of those  constituent  parts  of the  injected  cells,  which 
induce  the organism  of the  host to  form  anti-bodies.  The  weight 
of  evidence  seems  to  be  against  the  idea  that  the  cells  used  for 
immunization  remain  alive  indefinitely  in  the  new host and  induce 
the  resistance  by  their  life  functions.  Ehrlich's  atreptic  theory 
resembles  closely  the  exhaustion  theory  elaborated  by  Pasteur  in 
explanation  of  bacterial  immunity,  but  while  it  very  ingeniously 
explains  certain  phenomena  in  the  inmmnity  to  growth  of  tumor, 
it  does not seem to be sufficient for the complete elucidation  of all 
the data.  It  is also true  that  so far not a  single experimental  fact 
was adduced to prove the existence of anti-bodies in the blood serum 
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passive  innnunity  (the  experiments  of Clowes  and  Baeslack  (15) 
received no confirmation),  but such negative  results  can  hardly  be 
of great value,  since immunity  to growth  of cancer,  while possibly 
similar,  cannot  by the  nature  of the  process be identical  with  bac- 
terial  immunity. 
In  the  study of the phenomenon  of  inlmunity  to  cancer  growth, 
all the experience gained  in the study of bacterial  immunity should 
be closely followed, but new methods will have to be devised before 
the  actual  explanation  will  be  reached.  The  fact  that  an  animal 
organism  creates anti-bodies against  enzymes or any proteid matter 
introduced  into  the  circulation  is  a  certain  indication  of  the  fact 
that  the  existence  of  anti-bodies  in  the  imnmne  animal  cannot  be 
denied a priori.  The  aim  of the present  investigation  consisted  in 
the search  for a  substance which would not contain living cells and 
would still be able to inmmnize  an animal  against  the growth of an 
implanted  tumor.  The  work was  done with  Ehrlich's  sarcoma  of 
a  white rat,  for a  transplant  of which the writer is indebted  to Dr. 
Simon  Flexner.  This  tumor  is of a  very malignant  type,  takes  in 
from  IOO per cent.  to 8o per cent.  and  grows to a  very large  size, 
frequently measuring  two inches by one  inch  in about three weeks 
after inoculation. 
A  description  of the  different  methods  of  treatment  of  animals 
employed  in  order  to  create  a  condition  of  immunity  to  cancer 
growth  without the assistance of living  cells will now be given. 
Treatment  with Arsa~etin.--In  view of  the  great  inhibitory  in- 
fluence of the modern arsenical preparations  (atoxyl and arsazetin) 
on  trypanosomes  and  other  animal  parasites,  and  in  view  further 
of  the  frequent  reports  of  the  influence  of  arsenicals  on  human 
cancer,  it  is  interesting  to  learn  whether  these  drugs  have  any  in- 
fluence upon the growth of a  transplantable  sarcoma of a  rat. 
Sticker  (16)  reported  that  a  combination  of  blood-serum  and 
atoxyl  retards  growth  of his  transplantable  sarcoma  of a  dog and 
occasionally even arrests completely its development.  On the other 
hand,  Uhlenhuth  and  Weidanz  (17)  state  that  atoxyl  not  only 
does  not  retard  growth  of carcinoma  of a  mouse,  but  even  seems 
to enhance it. 
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carcinoma--and  this  fact  may  have  explained  the  discrepancy  be- 
tween  the  results  of  Sticker  and  Uhlenhuth  and  Weidanz,  the 
experiments  were  repeated  on  the  sarcoma  of  the  rat.  Arsazetin 
was used instead  of atoxyl,  since it was  found by Ehrlich  (18)  to 
be the more efficient of the  two. 
In  our  experiments,  forty  rats  were  treated  for  six  weeks  by 
hypodermic  injections  of one cubic centimeter  of 4  per cent.  solu- 
tion  of  arsazetin,  first  every two  days  and  then  every  four  days. 
Three  weeks  after  the  beginning  of  the  treatment  the  tumor  was 
inoculated. 
TABLE  I. 
Arsazetin. 
Treated animals,  Controls. 
Number of rats inoculated with tumor  ...............................  4o  2o 
Number of rats surviving at final examination  ......................  32  20 
Number of  rats with tumors  ...........................................  28  19 
Percentage of takes  .......................................................  87  95 
As Table I shows, the arsazetin had no influence upon the growth 
of the  tumor,  though  the  quantity  of the  drug  used  was  sufficient 
to  impair  considerably  the  general  health  of  the  animals.  In 
nearly  every  animal  a  condition  was  created  similar  to  the  state 
of a waltzing mouse. 
Treatment with Sodium  Oleate.--It was stated above, that  while 
no  protective  bodies  were  found  in  the  blood of  animals  immune 
to the growth of cancer by the ordinary methods used in bacteriol- 
ogy,  the  possibility  of  the  existence  in  the  blood  serum  of  some 
peculiar  kind  of anti-bodies  cannot  be excluded  a  priori.  The  in- 
vestigations  of  Kyes  (19)  and  Noguchi  (20)  have  shown  that  a 
certain  kind  of  cytolytic  immune  bodies  become  activated  on  the 
addition  of  lecithin  and  other  lipoids,  and  Noguchi  has  further 
proven  that  sodium oleate seems to possess the  strongest  cytolytic 
action of all the lipoid substances.  For this  reason a  certain  num- 
ber  of  animals  were  treated  with  an  injection  of  a  solution  of 
sodium oleate previous  to the  inoculation  of the  tumor. 
While the difference between the treated animals and the controls 
is  not  sufficient to  indicate  any actual  influence  of the  lipoid  used, 
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of such  a  method  of investigation,  this  part of the  research  is still 
being  continued  with  different variations. 
TABLE  II. 
Sodium  Oleate. 
Treated animals.  Controls. 
Number of rats inoculated with tumor  ...............................  2o  Io 
Number of rats surviving at final examination  ......................  I8  to 
Number of rats with tumors  ............................................  14  ~o 
Percentage of takes .....................................................  77  mo 
Treatment with Autolyzed  Tissue.--The investigations  of  Salk- 
owski  (2i),  M.  Jacoby  (22),  P.  g.  Levene  (23)  and  others, 
have  shown  that  a  great  many  of  the  so-called  vital  functions  of 
the cell are due to the activities of the endocellular enzymes.  These 
enzymes, while constituting  an integral  component part  of the cell, 
may remain  under  certain  conditions  uninjured  after  the  death  of 
the  cell.  Furthermore,  the  investigations  of  Petty  (24),  Blumen- 
thal and Wolf (25),  C. Neuberg  (26), Yoshimoto  (27)  and others 
have  shown that  the endocellular  enzymes of the cancer cells seem 
to  act  differently  both  qualitatively  and  quantitatively  from  the 
enzymes  of  normal  cells.  In  view  of  the  further  fact  that  the 
investigations  of  Mtiller  (28),  Opie  (29) ,  Blum  (3o),  Conradi 
(31)  and  others  have  shown that  these endocellular  ferments  play 
an  important  r61e  in  a  number  of pathological  processes,  and  may 
be the  means  to  which  the  organism  resorts  in  order  to  elaborate 
protective  substances--Conradi  and  Blum  have  shown  that  auto- 
lyzed tissue may act as an antitoxin--it  seems feasible a priori that 
the  resistance  induced  by  normal  mouse  or  rat  tissue  inoculated 
subcutaneously may also be due  not  to  the  function  of  a  live  cell, 
but  to  some  peculiar  type  of  an  endocellular  ferment.  This  as- 
sumption seems the more plausible since the best method of liberat- 
ing these  endocellular  enzymes  consists  in  the  autolysis  of  tissues, 
and  the  tissue  introduced  under  the  skin  in  order  to  induce  im- 
munity  is  put  under  conditions  most  favorable  for  subsequent 
autolysis. 
In  view  of  all  these  considerations,  a  series  of  animals  were 
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was the liver of " Nullers,"  that is, rats naturally  resistant to tumor 
implantation.  The  tissue  was  kept  under  asceptic  precautions  at 
body  temperature  for  two  weeks,  then  the  autolyzed  tissue  was 
mixed  with  about  double  the  quantity  of  normal  salt  solution, 
ground  thoroughly with  sand,  filtered,  and  one cubic centimeter  of 
the  solution injected  subcutaneously. 
TABLE  III. 
Treatment  with  Autolyzed  Tissue. 
Total. Control  p 
No. of rats inoculated with tumor,  ii  ii  ii  ii  Ii  ii  6o  6o  No. of rats surviving at the final examination, 2  5 
days after inoculation.  51  57 
No. of days before inoculation that autolyzed liver 
was injected. 
No.  was  of injected,  days  after  inoculation thatautolyzed liver  3  3  5  3  2  1  I2 
No. of rats without growth or with small abortive 
nodules.  ! 2  7  5  7  4  9  34  6 
No. of rats with tumors,  i  I7  5I 
Percent. oftakes,  i6o[3o  5o!3o  33] Io  34  85 
The  results  compare  quite  favorably  with  those  of  the  investi- 
gators  who induced  imnmnity  with  normal  tissue.  Thus  it  seems 
possible to produce in rats a  certain amount of resistance to growth 
of tumor by treatment  with tissue of which the cells are killed,  but 
the  endocellular  ferments  apparently  remain  active.  It  is  inter- 
esting  to  note  here  that  autolyzed  liver  tissue  seems  to  inmmnize 
equally  well,  whether  used  before  or  after  the  inoculation  of  the 
tumor,  which  fact  may  be  of  great  importance  in  view  of  the 
possibility expressed above, that  the  resisting  influence of the  host 
may be of two kinds,  one  to the  tumor  implantation,  the  other  to 
tumor growth. 
Ligation  of the Blood  Vessels of the Spleen.--The  spleen tissue 
gives the best results  in immunization,  as  is shown by the work of 
Bridr6,  and  it  is  also  the  most  active  tissue  on  autolysis,  but  the 
spleen of a  rat  is so small,  that  a  sufficient amount  of material  for 
autolysis  could  not be collected.  Another  method  was,  therefore, 
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vessels  of  the  spleen  were  ligated  and  from  four  to  twelve  days 
after  the  operation the  tumor  was  inoculated.  In  another  experi- 
ment the operation was c~one nine days after the inoculation. 
TABLE  IV. 
Ligation  of  Vessels  of the  Spleen. 
After the 
operation. 
Number of  rats inoculated with  tumor  ............  I6 
Number  of rats surviving  .............................  I4 
Number of rats with tumors  .........................  9 
Percentage of takes  ....................................  [  6I 
Betore the 
operation. 
IO 
IO 
IO 
IO0 
Controls. 
20 
20 
19 
95 
The table shows that  the immunizing  influence of such a  ligated 
spleen  is  not  as  strong  as  the  influence  of  autolyzed  liver  injected 
subcutaneously,  and  also that  this  immunizing  influence  is  exerted 
only on the grafting of the tumor and not on its continued  growth. 
The  action  of  the  ligated  spleen  is  most  probably  comparatively 
weak on account  of the  rapid  absorption  of the  organ,  which  pre- 
vents  the  autolysis,  and  indeed  no  traces  of  such  a  spleen  were 
found  in  the  abdominal  cavity two days  after  the  operation. 
Treatment with Alien Tissue.--The most important  facts adduced 
by Ehrlich  in  support  of his  atreptic  theory  of  tumor  growth  and 
immunity  consist  in  his  so-called  zig-zag  transplantations.  He 
showed,  namely,  that  when a  tumor  of a  mouse is  inoculated  into 
a  rat,  it  grows  normally  for eight  or  ten  days  and  then  ceases its 
growth  and  becomes absorbed,  but  if  before  the  absorption  takes 
place,  the  tumor is inoculated back into  a  mouse, it grows there to 
a  large  size.  Ehrlich's  explanation  of  this  phenomenon  is  that  a 
mouse tumor needs for its continued growth a certain  food stuff X, 
which  it  can  only find  in the  mouse organism.  When  it  is  intro- 
duced  into  the  rat,  it  carries  along  from  the  mouse  the  X  food, 
and as long as this  storage of specific food lasts, the tumor grows; 
when  it  is  exhausted,  the  tumor  cells  die,  but  when  they  are  re- 
turned  to  the  mouse,  they  find  again  the  necessary  food and  pro- 
liferate.  In  order  to  give  this  contention  a  further  test,  a  series 
of experiments was undertaken which consisted in the subcutaneous 
inoculation  into  a  rat,  of  the  normal  skin  and  spleen  tissue  of  a 
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the tumor.  The aim of this treatment was to accustom the tumor 
cells to mouse tissue and then to observe whether such a  rat tumor, 
which  had  the  opportunity to  obtain  during  its  growth  the  food 
supplied  by  the  inoculated  normal  mouse  tissue,  would  not  grow 
more readily when subsequently inoculated into a mouse. 
The results of this investigation were negative, but the extremely 
interesting  fact  was  observed  that  a  certain  number  of  the  rats 
treated with mouse tissue appeared immune against growth of the 
rat sarcoma.  The  following table will illustrate this phenomenon. 
TABLE  V. 
Treatment  with  Alien  Tissue. 
Treated animals.  Controls. 
Number of rats inoculated with tumor  ..............................  4 °  4 ° 
Number of rats surviving at final examination .....................  27  40 
Number of rats with  tumors  ............................................  xo  36 
Percentage of takes  .....................................................  37  9 ° 
Similar positive results were obtained recently by C. Lewin (32), 
who  succeeded  in  immunizing rats  with  mouse  tumors  and  vice 
versa.  This possibility to  immunize an animal against growth of 
tumor by treatment with alien tissue seems to indicate that Ehrlich's 
atreptic theory, while possibly of value in the  explanation of cer- 
tain facts, does not seem to have a universal application. 
Organ cells of a  mouse do not possess,  nor do they require any 
specific food of the rat,  which is the reason why a  rat tumor fails 
to grow indefinitely in a mouse.  When a  rat is immunized against 
growth  of  a  rat  tumor by  previous  treatment  with  mouse  tissue, 
such  a  failure  to  grow  cannot  be  ascribed  to  the  lack  of  proper 
nourishment within the host, since the previously inoculated mouse 
cells could not have absorbed such food. 
Another important conclusion which may be  reached  from this 
series  of  experiments  consists  in the  fact  that  this  immunizatior~ 
cannot be due to life activities of the cells,  since alien tissue could 
not  remain  alive  for thirteen days  after  it  was  introduced under 
the  skin.  Furthermore, this  phenomenon is  of practical  value  in 
the  further pursuance of this  investigation.  It  is  extremely diffi- 
cult, as was stated above, to obtain the necessary amount of tissue Isaac Levin.  605 
from these small  animals  for autolysis.  Since  it  was  found that 
alien tissue may be used for immunization, organs of large animals 
(dogs)  are being utilized  for autolysis,  and on addition of tumor 
tissue  of  a  rat,  heterolytic action  is  obtained.  This  is  of  great 
importance in a number of pathological processes and also in cancer, 
as is shown by the investigations of C.  Neuberg and others.  But 
these experiments are not yet sufficiently far advanced for conclu- 
sions  to be drawn.  The  same  is  true  for the experiments under- 
taken with the aim in view of obtaining  in large animals autolyfie 
antiferments  and  possibly,  therefore,  of  inducing  a  passive  im- 
munity to the growth of the transplantable tumors. 
The  results  obtained  in  this  investigation are  not  final;  a  great 
deal more work must be done on different tumors.  The difficulties 
encountered in  such  an  investigation  is  well  illustrated  by  a  very 
recent statement of Abderhalden and Pringsheim (33), that though 
using  the  best  methods  for  liberating  endocellular enzymes,  they 
occasionally do not find any enzymes in the solution, but the latter 
apparently become adherent to the filtrate and sand.  Consequently, 
while positive  results  in  our  research are convincing,  negative  re- 
sults may always be due to insufficient technique.  Different means 
then must be employed to liberate the greatest amount of ferments 
and entirely new methods will probably be created before conclusive 
results will be reached, but the viewpoint appears to be correct and 
the work seems to be pursued in the right direction.  Expressions 
like  "life activity of the cell"  or  "cellular  activity"  hardly have 
any significance in biology; the active constituent part  of the cell 
must be  found, and autolysis may be the road to  it.  The idea,  at 
least,  is  capable of stimulating' further research. 
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